The findings of higher BMI and a more frequent history of GDM in a previous pregnancy in the insulin group agree with earlier reports that weight and history of GDM are related to the need for pharmacological treatment in women with gestational diabetes [11–14]. This evidence concerns the gene INS and gestational diabetes.